Becton, Dickinson and Company BDX, popularly known as BD, received emergency use authorization (“EUA”) from the FDA for a new, rapid antigen test, which can simultaneously identify SARS-CoV-2, ...
(Reuters) - The U.S. Food and Drug Administration has granted emergency use authorization to Becton Dickinson and Co for a COVID-19 antigen test that can be administered at the point of care and ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the receipt of an order from the Dutch Ministry of Health for 9.2 million of its rapid, point-of-care, ...
Hosted on MSN
WHO prequalifies first rapid antigen tests for COVID-19, strengthening global diagnostic preparedness
More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic, the virus continues to circulate globally. While current data suggest ...
Over-the-counter multiplex tests for more than one illness may soon come to a pharmacy near you. Paco Burgada/iStock via Getty Images A scratchy, sore throat, a relentless fever, a pounding head and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results